CRISPR/Cas9 technology generated an ACC to GTG change at nt22681-22683 resulting in a threonine to valine substitution at amino acid 311 (p.T311V) in exon 6, resulting in a hypomorphic allele. (J:338825)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count